title: Osteosarcoma Overview.
abstract: Osteosarcoma (OS) is the most common primary malignancy of bone and patients with metastatic disease or recurrences continue to have very poor outcomes. Unfortunately, little prognostic improvement has been generated from the last 20 years of research and a new perspective is warranted. OS is extremely heterogeneous in both its origins and manifestations. Although multiple associations have been made between the development of osteosarcoma and race, gender, age, various genomic alterations, and exposure situations among others, the etiology remains unclear and controversial. Noninvasive diagnostic methods include serum markers like alkaline phosphatase and a growing variety of imaging techniques including X-ray, computed tomography, magnetic resonance imaging, and positron emission as well as combinations thereof. Still, biopsy and microscopic examination are required to confirm the diagnosis and carry additional prognostic implications such as subtype classification and histological response to neoadjuvant chemotherapy. The current standard of care combines surgical and chemotherapeutic techniques, with a multitude of experimental biologics and small molecules currently in development and some in clinical trial phases. In this review, in addition to summarizing the current understanding of OS etiology, diagnostic methods, and the current standard of care, our group describes various experimental therapeutics and provides evidence to encourage a potential paradigm shift toward the introduction of immunomodulation, which may offer a more comprehensive approach to battling cancer pleomorphism.
authors.affiliation: Department of Orthopaedics, West Virginia University, Morgantown, WV, USA. blindsey@hsc.wvu.edu.
authors.forename: Brock A
authors.initials: BA
authors.lastname: Lindsey
authors.affiliation: Department of Orthopaedics, West Virginia University, Morgantown, WV, USA.
authors.forename: Justin E
authors.initials: JE
authors.lastname: Markel
authors.affiliation: Division of Pediatrics, MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Eugenie S
authors.initials: ES
authors.lastname: Kleinerman
keywords: Bone cancer; Bone sarcoma; Metastatic osteosarcoma; Osteosarcoma; Treatment for sarcoma